Search Browse Earnings

Acumen Pharmaceuticals, Inc. — SlamSEC

Acumen Pharmaceuticals, Inc.

Nasdaq:ABOS

Biological Products, (No Diagnostic Substances)·NEWTON, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$61.1M

FY 2024

Net Income

-$52.4M

FY 2024

EPS (Diluted)

-$1.08

FY 2024

Stock Price

$3.35

+6.5%

2026-03-10

52W Range

$0.86 – $3.50

P/E Ratio

-3.1x

Market Cap

$202.9M

Cash

$66.9M

FY 2024

Total Debt

$29.9M

FY 2024

Net Cash

$37.0M

FY 2024

Enterprise Value

$165.9M

Debt / EBITDA

0.6x

FY 2024

EV / EBITDA

-2.7x

Employees

—

CEO

Oconnell Daniel Joseph

CFO

Zuga Matt